Both p53 and Ki67 proteins demonstrated significant differences in expression between the four molecular subtypes (P < 0.01), between the ER+ and ER− groups (P < 0.01), and between HER-2+ and HER-2− breast cancer groups (P < 0.01). This evidence concerns the gene ESR1 and breast carcinoma.